TreeWAS – Variant ID: rs457162

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R00.0 Tachycardia, unspecified	0.061	0.939	0.000
D32.0 Cerebral meninges	0.038	0.962	0.000
D32.9 Meninges, unspecified	0.034	0.966	0.000
D32 Benign neoplasm of meninges	0.033	0.967	0.000
R00 Abnormalities of heart beat	0.029	0.971	0.000
R00.8 Other and unspecified abnormalities of heart beat	0.027	0.973	0.000
K66.0 Peritoneal adhesions	0.000	0.974	0.026
C79 Secondary malignant neoplasm of other sites	0.024	0.976	0.000
D32.1 Spinal meninges	0.024	0.976	0.000
C78.7 Secondary malignant neoplasm of liver	0.022	0.978	0.000
R00.2 Palpitations	0.022	0.978	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.022	0.978	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.021	0.979	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.021	0.979	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.021	0.979	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.020	0.980	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.020	0.980	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.020	0.980	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.019	0.981	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.019	0.981	0.000
C79.6 Secondary malignant neoplasm of ovary	0.018	0.982	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.017	0.982	0.000
C79.2 Secondary malignant neoplasm of skin	0.017	0.983	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.017	0.983	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.016	0.984	0.000
C78.0 Secondary malignant neoplasm of lung	0.016	0.984	0.000
C77.1 Intrathoracic lymph nodes	0.015	0.985	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.015	0.985	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.015	0.985	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.015	0.985	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.015	0.985	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.014	0.986	0.000
C77.9 Lymph node, unspecified	0.014	0.986	0.000
C77.8 Lymph nodes of multiple regions	0.013	0.986	0.000
C80 Malignant neoplasm without specification of site	0.013	0.987	0.000
K66 Other disorders of peritoneum	0.000	0.987	0.013
C77.4 Inguinal and lower limb lymph nodes	0.012	0.988	0.000
C78.2 Secondary malignant neoplasm of pleura	0.012	0.988	0.000
C77.5 Intrapelvic lymph nodes	0.012	0.988	0.000
G57.6 Lesion of plantar nerve	0.012	0.988	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.011	0.989	0.000
C76.7 Other ill-defined sites	0.011	0.989	0.000
C76.5 Lower limb	0.011	0.989	0.000
C76.4 Upper limb	0.011	0.989	0.000
C76.3 Pelvis	0.011	0.989	0.000
C76.2 Abdomen	0.011	0.989	0.000
C76.1 Thorax	0.011	0.989	0.000
C76.0 Head, face and neck	0.011	0.989	0.000
C77.3 Axillary and upper limb lymph nodes	0.011	0.989	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.011	0.989	0.000
Z37.0 Single live birth	0.000	0.990	0.010
C34.9 Bronchus or lung, unspecified	0.010	0.990	0.000
C34 Malignant neoplasm of bronchus and lung	0.010	0.990	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.009	0.991	0.000
K66.9 Disorder of peritoneum, unspecified	0.000	0.991	0.009
K66.1 Haemoperitoneum	0.000	0.991	0.009
N32.9 Bladder disorder, unspecified	0.009	0.991	0.000
C34.3 Lower lobe, bronchus or lung	0.009	0.991	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.009	0.991	0.000
Z96.0 Presence of urogenital implants	0.009	0.991	0.000
G57 Mononeuropathies of lower limb	0.008	0.992	0.000
K66.8 Other specified disorders of peritoneum	0.000	0.992	0.008
G57.8 Other mononeuropathies of lower limb	0.008	0.992	0.000
C34.0 Main bronchus	0.008	0.992	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.008	0.992	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.008	0.992	0.000
J84 Other interstitial pulmonary diseases	0.008	0.992	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.008	0.992	0.000
C32 Malignant neoplasm of larynx	0.008	0.992	0.000
C34.8 Overlapping lesion of bronchus and lung	0.007	0.993	0.000
D05 Carcinoma in situ of breast	0.007	0.993	0.000
J84.8 Other specified interstitial pulmonary diseases	0.007	0.993	0.000
D25.9 Leiomyoma of uterus, unspecified	0.000	0.993	0.007
D05.1 Intraductal carcinoma in situ	0.007	0.993	0.000
R63 Symptoms and signs concerning food and fluid intake	0.007	0.993	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.007	0.993	0.000
R63.1 Polydipsia	0.006	0.993	0.000
G57.1 Meralgia paraesthetica	0.006	0.993	0.000
C34.1 Upper lobe, bronchus or lung	0.006	0.994	0.000
D05.0 Lobular carcinoma in situ	0.006	0.994	0.000
C32.1 Supraglottis	0.006	0.994	0.000
C32.0 Glottis	0.006	0.994	0.000
G57.9 Mononeuropathy of lower limb, unspecified	0.006	0.994	0.000
G57.5 Tarsal tunnel syndrome	0.006	0.994	0.000
G57.4 Lesion of medial popliteal nerve	0.006	0.994	0.000
G57.3 Lesion of lateral popliteal nerve	0.006	0.994	0.000
G57.2 Lesion of femoral nerve	0.006	0.994	0.000
G57.0 Lesion of sciatic nerve	0.006	0.994	0.000
C32.9 Larynx, unspecified	0.006	0.994	0.000
C34.2 Middle lobe, bronchus or lung	0.006	0.994	0.000
Z37 Outcome of delivery	0.000	0.994	0.006
R63.5 Abnormal weight gain	0.006	0.994	0.000
I34.0 Mitral (valve) insufficiency	0.006	0.994	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.006	0.994	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.006	0.994	0.000
C31 Malignant neoplasm of accessory sinuses	0.006	0.994	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.006	0.994	0.000
C37 Malignant neoplasm of thymus	0.006	0.994	0.000
C33 Malignant neoplasm of trachea	0.006	0.994	0.000
J84.0 Alveolar and parietoalveolar conditions	0.006	0.994	0.000
C77.0 Lymph nodes of head, face and neck	0.006	0.994	0.000
C80.9 Malignant neoplasm, unspecified	0.005	0.994	0.001
I34.1 Mitral (valve) prolapse	0.006	0.994	0.000
C32.8 Overlapping lesion of larynx	0.006	0.994	0.000
C32.3 Laryngeal cartilage	0.006	0.994	0.000
C32.2 Subglottis	0.006	0.994	0.000
R63.4 Abnormal weight loss	0.006	0.994	0.000
Z37.2 Twins, both liveborn	0.000	0.994	0.006
D05.7 Other carcinoma in situ of breast	0.006	0.994	0.000
C61 Malignant neoplasm of prostate	0.005	0.995	0.000
Chapter II Neoplasms	0.005	0.995	0.000
D00-D09 In situ neoplasms	0.005	0.995	0.000
I34 Nonrheumatic mitral valve disorders	0.005	0.995	0.000
C77.2 Intra-abdominal lymph nodes	0.005	0.995	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.005	0.995	0.000
C60-C63 Malignant neoplasms of male genital organs	0.005	0.995	0.000
R63.3 Feeding difficulties and mismanagement	0.005	0.995	0.000
R63.6 Insufficient intake of food and water due to self neglect	0.005	0.995	0.000
R63.2 Polyphagia	0.005	0.995	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.995	0.000
Z37.9 Outcome of delivery unspecified	0.000	0.995	0.005
Z37.7 Other multiple births, all stillborn	0.000	0.995	0.005
Z37.6 Other multiple births, some liveborn	0.000	0.995	0.005
Z37.5 Other multiple births, all liveborn	0.000	0.995	0.005
Z37.4 Twins, both stillborn	0.000	0.995	0.005
Z37.3 Twins, one liveborn and one stillborn	0.000	0.995	0.005
Z37.1 Single stillbirth	0.000	0.995	0.005
C30.1 Middle ear	0.004	0.995	0.000
C30.0 Nasal cavity	0.004	0.995	0.000
C31.9 Accessory sinus, unspecified	0.004	0.995	0.000
C31.8 Overlapping lesion of accessory sinuses	0.004	0.995	0.000
C31.3 Sphenoidal sinus	0.004	0.995	0.000
C31.2 Frontal sinus	0.004	0.995	0.000
C31.1 Ethmoidal sinus	0.004	0.995	0.000
C31.0 Maxillary sinus	0.004	0.995	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.004	0.995	0.000
C38.4 Pleura	0.004	0.995	0.000
C38.3 Mediastinum, part unspecified	0.004	0.995	0.000
C38.2 Posterior mediastinum	0.004	0.995	0.000
C38.1 Anterior mediastinum	0.004	0.995	0.000
C38.0 Heart	0.004	0.995	0.000
C39.9 Ill-defined sites within the respiratory system	0.004	0.995	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.004	0.995	0.000
C39.0 Upper respiratory tract, part unspecified	0.004	0.995	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.005	0.995	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.005	0.995	0.000
C82.2 Large cell, follicular	0.004	0.995	0.000
Y43.3 Other antineoplastic drugs	0.005	0.995	0.000
K65-K67 Diseases of peritoneum	0.000	0.995	0.004
B37.0 Candidal stomatitis	0.004	0.996	0.000
D06 Carcinoma in situ of cervix uteri	0.004	0.996	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.004	0.996	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.004	0.996	0.000
R63.0 Anorexia	0.004	0.996	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.004	0.996	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.004	0.996	0.000
Y43 Primarily systemic agents	0.004	0.996	0.000
I34.8 Other nonrheumatic mitral valve disorders	0.004	0.996	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.004	0.996	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.004	0.996	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.004	0.996	0.000
C82.6 Cutaneous follicle centre lymphoma	0.004	0.996	0.000
C82.5 Diffuse follicle centre lymphoma	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.004	0.996	0.000
C82.3 Follicular lymphoma grade IIIa	0.004	0.996	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.004	0.996	0.000
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
D09 Carcinoma in situ of other and unspecified sites	0.004	0.996	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.004	0.996	0.000
C60 Malignant neoplasm of penis	0.004	0.996	0.000
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.004	0.996	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C95 Leukaemia of unspecified cell type	0.004	0.996	0.000
C94 Other leukaemias of specified cell type	0.004	0.996	0.000
C93 Monocytic leukaemia	0.004	0.996	0.000
C86 Other specified types of T/NK-cell lymphoma	0.004	0.996	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.004	0.996	0.000
C83.7 Burkitt's tumour	0.004	0.996	0.000
D25 Leiomyoma of uterus	0.000	0.996	0.004
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.004	0.996	0.000
C62 Malignant neoplasm of testis	0.004	0.996	0.000
C92 Myeloid leukaemia	0.004	0.996	0.000
Y43.1 Antineoplastic antimetabolites	0.004	0.996	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.003	0.996	0.000
D25.1 Intramural leiomyoma of uterus	0.000	0.996	0.004
Y43.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
C83.1 Small cleaved cell (diffuse)	0.003	0.996	0.000
C90.2 Plasmacytoma, extramedullary	0.003	0.996	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.003	0.996	0.000
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.996	0.003
C49 Malignant neoplasm of other connective and soft tissue	0.003	0.996	0.000
D06.9 Cervix, unspecified	0.003	0.997	0.000
D07.1 Vulva	0.003	0.997	0.000
D10 Benign neoplasm of mouth and pharynx	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
D03 Melanoma in situ	0.003	0.997	0.000
D23.9 Skin, unspecified	0.003	0.997	0.000
C81 Hodgkin's disease	0.003	0.997	0.000
D10.3 Other and unspecified parts of mouth	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.003	0.997	0.000
D06.7 Other parts of cervix	0.003	0.997	0.000
D06.1 Exocervix	0.003	0.997	0.000
D06.0 Endocervix	0.003	0.997	0.000
B37 Candidiasis	0.003	0.997	0.000
C50-C50 Malignant neoplasm of breast	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
C83.3 Large cell (diffuse)	0.003	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
B37.9 Candidiasis, unspecified	0.003	0.997	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.003	0.997	0.000
C46 Kaposi's sarcoma	0.003	0.997	0.000
D10-D36 Benign neoplasms	0.003	0.997	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.003	0.997	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.003	0.997	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.003	0.997	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.003	0.997	0.000
D00.2 Stomach	0.003	0.997	0.000
D00.1 Oesophagus	0.003	0.997	0.000
D00.0 Lip, oral cavity and pharynx	0.003	0.997	0.000
D01.9 Digestive organ, unspecified	0.003	0.997	0.000
D01.7 Other specified digestive organs	0.003	0.997	0.000
D01.5 Liver, gallbladder and bile ducts	0.003	0.997	0.000
D01.4 Other and unspecified parts of intestine	0.003	0.997	0.000
D01.3 Anus and anal canal	0.003	0.997	0.000
D01.2 Rectum	0.003	0.997	0.000
D01.1 Rectosigmoid junction	0.003	0.997	0.000
D01.0 Colon	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.003	0.997	0.000
C84.5 Other and unspecified T-cell lymphomas	0.003	0.997	0.000
N28.1 Cyst of kidney, acquired	0.000	0.997	0.003
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)	0.003	0.997	0.000
D02.4 Respiratory system, unspecified	0.003	0.997	0.000
D02.3 Other parts of respiratory system	0.003	0.997	0.000
D02.2 Bronchus and lung	0.003	0.997	0.000
D02.1 Trachea	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.003	0.997	0.000
C74 Malignant neoplasm of adrenal gland	0.003	0.997	0.000
D09.9 Carcinoma in situ, unspecified	0.003	0.997	0.000
D09.7 Carcinoma in situ of other specified sites	0.003	0.997	0.000
D09.3 Thyroid and other endocrine glands	0.003	0.997	0.000
D09.2 Eye	0.003	0.997	0.000
D09.1 Other and unspecified urinary organs	0.003	0.997	0.000
C60.9 Penis, unspecified	0.003	0.997	0.000
C60.8 Overlapping lesion of penis	0.003	0.997	0.000
C60.2 Body of penis	0.003	0.997	0.000
C60.1 Glans penis	0.003	0.997	0.000
C60.0 Prepuce	0.003	0.997	0.000
C63.9 Male genital organ, unspecified	0.003	0.997	0.000
C63.8 Overlapping lesion of male genital organs	0.003	0.997	0.000
C63.7 Other specified male genital organs	0.003	0.997	0.000
C63.2 Scrotum	0.003	0.997	0.000
C63.1 Spermatic cord	0.003	0.997	0.000
C63.0 Epididymis	0.003	0.997	0.000
D10.0 Lip	0.003	0.997	0.000
M24.8 Other specific joint derangements, not elsewhere classified	0.003	0.997	0.000
D34 Benign neoplasm of thyroid gland	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.003	0.997	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.003	0.997	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.003	0.997	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.003	0.997	0.000
C84.4 Peripheral T-cell lymphoma	0.003	0.997	0.000
C84.3 Lymphoepithelioid lymphoma	0.003	0.997	0.000
C84.2 T-zone lymphoma	0.003	0.997	0.000
C84.1 Sezary's diease	0.003	0.997	0.000
C84.0 Mycosis fungoides	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
D02.0 Larynx	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
D25.2 Subserosal leiomyoma of uterus	0.000	0.997	0.003
D33 Benign neoplasm of brain and other parts of central nervous system	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
C93.9 Monocytic leukaemia, unspecified	0.003	0.997	0.000
C93.7 Other monocytic leukaemia	0.003	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.003	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.003	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.003	0.997	0.000
C93.0 Acute monocytic leukaemia	0.003	0.997	0.000
C94.7 Other specified leukaemias	0.003	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.003	0.997	0.000
C94.5 Acute myelofibrosis	0.003	0.997	0.000
C94.4 Acute panmyelosis	0.003	0.997	0.000
C94.3 Mast cell leukaemia	0.003	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.003	0.997	0.000
C94.1 Chronic erythraemia	0.003	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.003	0.997	0.000
C96.8 Histiocytic sarcoma	0.003	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.003	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.003	0.997	0.000
C96.3 True histiocytic lymphoma	0.003	0.997	0.000
C96.2 Malignant mast cell tumour	0.003	0.997	0.000
C96.1 Malignant histiocytosis	0.003	0.997	0.000
C96.0 Letterer-Siwe disease	0.003	0.997	0.000
D03.5 Melanoma in situ of trunk	0.003	0.997	0.000
D09.0 Bladder	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
C73 Malignant neoplasm of thyroid gland	0.003	0.997	0.000
D07.6 Other and unspecified male genital organs	0.003	0.997	0.000
D07.4 Penis	0.003	0.997	0.000
D07.3 Other and unspecified female genital organs	0.003	0.997	0.000
D07.2 Vagina	0.003	0.997	0.000
D07.0 Endometrium	0.003	0.997	0.000
C09 Malignant neoplasm of tonsil	0.003	0.997	0.000
K65 Peritonitis	0.000	0.997	0.003
C48.0 Retroperitoneum	0.003	0.997	0.000
D63.0 Anaemia in neoplastic disease	0.003	0.997	0.000
N43.3 Hydrocele, unspecified	0.000	0.997	0.003
D33.2 Brain, unspecified	0.003	0.997	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.003	0.997	0.000
C13 Malignant neoplasm of hypopharynx	0.003	0.997	0.000
C11 Malignant neoplasm of nasopharynx	0.003	0.997	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.003	0.997	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.003	0.997	0.000
C05 Malignant neoplasm of palate	0.003	0.997	0.000
C04 Malignant neoplasm of floor of mouth	0.003	0.997	0.000
C03 Malignant neoplasm of gum	0.003	0.997	0.000
C00 Malignant neoplasm of lip	0.003	0.997	0.000
C12 Malignant neoplasm of pyriform sinus	0.003	0.997	0.000
C01 Malignant neoplasm of base of tongue	0.003	0.997	0.000
B37.8 Candidiasis of other sites	0.003	0.997	0.000
C83.0 Small cell (diffuse)	0.003	0.997	0.000
C10 Malignant neoplasm of oropharynx	0.003	0.997	0.000
C62.1 Descended testis	0.003	0.997	0.000
C62.0 Undescended testis	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.003	0.997	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.003	0.997	0.000
C92.7 Other myeloid leukaemia	0.003	0.997	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.003	0.997	0.000
C92.5 Acute myelomonocytic leukaemia	0.003	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.003	0.997	0.000
C92.3 Myeloid sarcoma	0.003	0.997	0.000
C92.2 Subacute myeloid leukaemia	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
C64-C68 Malignant neoplasms of urinary tract	0.003	0.997	0.000
C48.2 Peritoneum, unspecified	0.003	0.997	0.000
C56 Malignant neoplasm of ovary	0.000	0.997	0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.003	0.997	0.000
C48.1 Specified parts of peritoneum	0.003	0.997	0.000
K67.8 Other disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.997	0.003
K67.3 Tuberculous peritonitis	0.000	0.997	0.003
K67.2 Syphilitic peritonitis	0.000	0.997	0.003
K67.1 Gonococcal peritonitis	0.000	0.997	0.003
K67.0 Chlamydial peritonitis	0.000	0.997	0.003
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.997	0.003
D26 Other benign neoplasms of uterus	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
C49.9 Connective and soft tissue, unspecified	0.003	0.997	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.003	0.997	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.003	0.997	0.000
C49.5 Connective and soft tissue of pelvis	0.003	0.997	0.000
C49.4 Connective and soft tissue of abdomen	0.003	0.997	0.000
C49.3 Connective and soft tissue of thorax	0.003	0.997	0.000
C49.0 Connective and soft tissue of head, face and neck	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
D10.9 Pharynx, unspecified	0.003	0.997	0.000
D10.7 Hypopharynx	0.003	0.997	0.000
D10.6 Nasopharynx	0.003	0.997	0.000
D10.5 Other parts of oropharynx	0.003	0.997	0.000
D10.4 Tonsil	0.003	0.997	0.000
D10.2 Floor of mouth	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.997	0.003
D21 Other benign neoplasms of connective and other soft tissue	0.003	0.997	0.000
C51-C58 Malignant neoplasms of female genital organs	0.002	0.997	0.001
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
D03.9 Melanoma in situ, unspecified	0.003	0.997	0.000
D03.8 Melanoma in situ of other sites	0.003	0.997	0.000
D03.4 Melanoma in situ of scalp and neck	0.003	0.997	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.003	0.997	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.003	0.997	0.000
D03.0 Melanoma in situ of lip	0.003	0.997	0.000
D33.0 Brain, supratentorial	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.003	0.997	0.000
D14 Benign neoplasm of middle ear and respiratory system	0.003	0.997	0.000
C07 Malignant neoplasm of parotid gland	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
C91.9 Lymphoid leukaemia, unspecified	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.997	0.000
C91.7 Other lymphoid leukaemia	0.003	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.997	0.000
C91.5 Adult T-cell leukaemia	0.003	0.997	0.000
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.997	0.000
D10.1 Tongue	0.003	0.997	0.000
B37.4 Candidiasis of other urogenital sites	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
D23 Other benign neoplasms of skin	0.003	0.997	0.000
B37.7 Candidal septicaemia	0.003	0.997	0.000
B37.6 Candidal endocarditis	0.003	0.997	0.000
B37.5 Candidal meningitis	0.003	0.997	0.000
B37.2 Candidiasis of skin and nail	0.003	0.997	0.000
B37.1 Pulmonary candidiasis	0.003	0.997	0.000
C45 Mesothelioma	0.002	0.997	0.000
C46.9 Kaposi's sarcoma, unspecified	0.002	0.997	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.002	0.997	0.000
C46.7 Kaposi's sarcoma of other sites	0.002	0.997	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.002	0.997	0.000
C46.2 Kaposi's sarcoma of palate	0.002	0.997	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.002	0.997	0.000
C46.0 Kaposi's sarcoma of skin	0.002	0.997	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.002	0.997	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.002	0.997	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.002	0.997	0.000
C47.5 Peripheral nerves of pelvis	0.002	0.997	0.000
C47.4 Peripheral nerves of abdomen	0.002	0.997	0.000
C47.3 Peripheral nerves of thorax	0.002	0.997	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.002	0.997	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.002	0.997	0.000
C47.0 Peripheral nerves of head, face and neck	0.002	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.997	0.000
C85.0 Lymphosarcoma	0.002	0.997	0.000
C91.0 Acute lymphoblastic leukaemia	0.002	0.997	0.000
C40.9 Bone and articular cartilage of limb, unspecified	0.002	0.997	0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs	0.002	0.997	0.000
C40.3 Short bones of lower limb	0.002	0.997	0.000
C40.2 Long bones of lower limb	0.002	0.997	0.000
C40.1 Short bones of upper limb	0.002	0.997	0.000
C40.0 Scapula and long bones of upper limb	0.002	0.997	0.000
C41.9 Bone and articular cartilage, unspecified	0.002	0.997	0.000
C41.8 Overlapping lesion of bone and articular cartilage	0.002	0.997	0.000
C41.4 Pelvic bones, sacrum and coccyx	0.002	0.997	0.000
C41.3 Ribs, sternum and clavicle	0.002	0.997	0.000
C41.2 Vertebral column	0.002	0.997	0.000
C41.1 Mandible	0.002	0.997	0.000
C41.0 Bones of skull and face	0.002	0.997	0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.002	0.997	0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.002	0.997	0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)	0.002	0.997	0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)	0.002	0.997	0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)	0.002	0.997	0.000
D29 Benign neoplasm of male genital organs	0.002	0.997	0.000
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.002	0.997	0.000
D19 Benign neoplasm of mesothelial tissue	0.002	0.997	0.000
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.002	0.997	0.000
D26.0 Cervix uteri	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
C74.9 Adrenal gland, unspecified	0.002	0.997	0.000
C74.1 Medulla of adrenal gland	0.002	0.997	0.000
C74.0 Cortex of adrenal gland	0.002	0.997	0.000
C75.9 Endocrine gland, unspecified	0.002	0.997	0.000
C75.8 Pluriglandular involvement, unspecified	0.002	0.997	0.000
C75.5 Aortic body and other paraganglia	0.002	0.997	0.000
C75.4 Carotid body	0.002	0.997	0.000
C75.3 Pineal gland	0.002	0.997	0.000
C75.2 Craniopharyngeal duct	0.002	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations